Elacestrant dihydrochloride
CAS 1349723-93-8
In Stock
Elacestrant dihydrochloride
Cat. No. ANT-ELC-001CAS 1349723-93-8In Stock
Technical Data
Cat. No.ANT-ELC-001
CAS1349723-93-8
Mol. FormulaC30H40Cl2N2O2
Mol. Weight531.56 g/mol
IUPAC(6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol;dihydrochloride
SMILESOC1=CC=C2C[C@H](C3=CC=C(OC)C=C3N(CC)CC4=CC=C(CCNCC)C=C4)CCC2=C1.[H]Cl.[H]Cl
InChIInChI=1S/C30H38N2O2.2ClH/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26;;/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3;2*1H/t26-;;/m1../s1
InChI KeyXGFHYCAZOCBCRQ-FBHGDYMESA-N
Purity—
Description
Overview
Elacestrant dihydrochloride (sold as Orserdu) is an oral Selective Estrogen Receptor Degrader (SERD) approved to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. It is indicated for postmenopausal women and men whose disease progressed after endocrine therapy, acting by binding to and degrading estrogen receptors
Anant Labs manufacture and furnish high quality Elacestrant dihydrochloride impurities for global markets. Our Elacestrant dihydrochloride EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
(R)-6-(2-(Ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol dihydrochloride(6R)-6-{2-[ethyl({4-[2-(ethylamino)ethyl]phenyl}methyl)amino]-4-methoxyphenyl}-5,6,7,8-tetrahydronaphthalen-2-ol hydrochloride (1:2)(R)-6-[2-[Ethyl[4-(2-ethylaminoethyl)benzyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol DihydrochlorideElacestrant dihydrochloride1349723-93-8Elacestrant hydrochlorideRAD1901 dihydrochlorideRAD-1901 dihydrochloride8NZT0PR8AL2-Naphthalenol, 6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydro-, hydrochloride (1:2), (6R)-